The role of high mobility group box 1 in neuroinflammatory related diseases
Authors:
Open Access
- 22 March 2023
- journal article
- review article
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 161, 114541
Abstract
No abstract availableKeywords
This publication has 99 references indexed in Scilit:
- Elevated serum autoantibody against high mobility group box 1 as a potent surrogate biomarker for amyotrophic lateral sclerosisNeurobiology of Disease, 2013
- High-mobility group box 1 protein (HMGB1) neutralization ameliorates experimental autoimmune encephalomyelitisJournal of Autoimmunity, 2013
- Anti-high mobility group box 1 monoclonal antibody ameliorates experimental autoimmune encephalomyelitisClinical and Experimental Immunology, 2013
- HMGB1 is involved in autophagy inhibition caused by SNCA/α-synuclein overexpressionAutophagy, 2013
- Brain-Immune Interactions and Ischemic StrokeArchives of Neurology, 2012
- Toll-like receptor signaling in amyotrophic lateral sclerosis spinal cord tissueNeuroscience, 2011
- Astrocyte–endothelial interactions at the blood–brain barrierNature Reviews Neuroscience, 2006
- Release of chromatin protein HMGB1 by necrotic cells triggers inflammationNature, 2002
- Isolation and Characterisation of Two Calf‐Thymus Chromatin Non‐Histone Proteins with High Contents of Acidic and Basic Amino AcidsEuropean Journal of Biochemistry, 1973
- A New Group of Chromatin‐Associated Proteins with a High Content of Acidic and Basic Amino AcidsEuropean Journal of Biochemistry, 1973